Utility of magnetic resonance imaging in the evaluation of patients with inflammatory myopathies

Current Rheumatology Reports

Volumn 3, Issue 4, 2001, Pages 334-345

  Park, Jane H ^a   Olsen, Nancy J ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dermatomyositis; Inclusion Body Myositis; Inflammatory Myopathy; Maximum Voluntary Contraction; Myositis

Indexed keywords

COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; ECONOMICS; HUMAN; INCLUSION BODY MYOSITIS; METABOLISM; MYOSITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMYOSITIS; RADIOGRAPHY; REVIEW; TIME;

COST-BENEFIT ANALYSIS; DERMATOMYOSITIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; MYOSITIS; MYOSITIS, INCLUSION BODY; POLYMYOSITIS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0035432344     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-001-0038-x     Document Type: Article

References (55)

1. Hodler J, Yu JS, Steinert HC, Resnick D: MR imaging versus alternative imaging techniques. Magn Reson Imaging Clin North Am 1995, 3:591–608.
2. Park JH, Olsen NJ: Skeletal muscle imaging for the evaluation of myopathies. In Diseases of Skeletal Muscle. Edited by Wortmann RL. Philadelphia: Lippincott Williams and Wilkins; 2000:293–312.
3. Reimers CD, Fleckenstein JL, Witt TN, Muller-Felber W, Pongratz DE: Muscular ultrasound in idiopathic inflammatory myopathies of adults. J Neurol Sci 1993, 116:82–92. This paper demonstrates that, if the preferred MRI examinations are impossible, ultrasound may be used to provide a quantitative evaluation of inflammatory myopathies.
4. Reimers CD, Finkenstaedt M: Muscle imaging in inflammatory myopathies. Curr Opin Rheumatol 1997, 9:475–485. DOI: 10.1097/00002281-199711000-00002
5. Park JH, Vansant JP, Kumar NG, et al.: Dermatomyositis: correlative MR imaging and P-31 MR spectroscopy for quantitative characterization of inflammatory disease. Radiology 1990, 177:473–479.
6. Park JH, Vital T, Ryder N, et al.: MR imaging and P-31 MR spectroscopy provide unique quantitative data for longitudinal management of patients with dermatomyositis. Arthritis Rheum 1994, 37:736–746. There are few, if any, quantitative tests for longitudinal evaluation of patients with inflammatory myopathies. This paper verifies that MRI and P-31 MRS provide useful, quantitative data for characterizing patients with dermatomyositis and for planning therapeutic regimes. DOI: 10.1002/art.1780370519
7. Fraser DD, Frank JA, Dalakas M, et al.: Magnetic resonance imaging in the idiopathic inflammatory myopathies. J Rheumatol 1991, 18:1693–1699. This study represents the first application of the MRI STIR sequences for accurate visualization of inflammation in dermatomyositis and polymyositis. The variations in the patterns of inflammation are described and illustrated with a variety of images. Detection of inflammation in myofacial tissue and subcutaneous fat was also demonstrated with this technique.
8. Olsen NJ, Park JH: Inflammatory myopathies: issues in diagnosis and management. Arthritis Care Res 1997, 10:200–207. DOI: 10.1002/art.1790100308
9. Adams EM, Pucino F, Yarboro C, et al.: A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis and examination of endpoint measures. J Rheumatol 1999, 26:352–360.
10. Schweitzer ME, Fort J: Cost-effectiveness of MR imaging in evaluating polymyositis. Am J Radiol 1995, 165:1469–1471.
11. Pitt AM, Fleckenstein JL, Greenlee RG Jr, et al.: MRI-guided biopsy in inflammatory myopathy: initial results. Magn Reson Imaging 1993, 11:1093–1099. DOI: 10.1016/0730-725X(93)90236-7
12. Stark DD, Bradley WG: Magnetic Resonance Imaging, edn 3. St. Louis: Mosby; 1999, 1:295–300.
13. Boutin RD, Brossmann J, Sartoris DJ, Reilly D, Resnick D: Update on imaging of orthopedic infections. Orthop Clin North Am 1998, 29:41–66. DOI: 10.1016/S0030-5898(05)70006-7
14. Fleckenstein JL, Reimers CD: Inflammatory myopathies: radiologic evaluation. Radiol Clin North Am 1996, 34:427–439. This review provides an excellent comparison of MRI and ultrasound for the visualization of the imaging abnormalities in inflammatory myopathies, namely, inflammation, fat infiltration, calcification, atrophy, location of pathologic changes in specific muscles, abnormal vascularization, and blood flow.
15. Hawley RJJ, Schellinger D, O’Doherty DS: Computed tomographic patterns of muscles in neuromuscular diseases. Arch Neurol 1984, 41:383–387.
16. Jouve JL, Cottalorda J, Bollini G, Scheiner C, Daoud A: Myositis ossificans: report of seven cases in children. J Pediatr Orthop B 1997, 6:33–41.
17. Kaufman LD, Gruber BL, Gerstman DP, Kaell AT: Preliminary observations on the role of magnetic resonance imaging for polymyositis and dermatomyositis. Ann Rheum Dis 1987, 46:569–572. DOI: 10.1136/ard.46.8.569
18. Stiglbauer R, Graninger W, Prayer L, et al.: Polymyositis: MRI-appearance at 1.5 T and correlation to clinical findings. Clin Radiol 1993, 48:244–248. DOI: 10.1016/S0009-9260(05)80305-8
19. Hernandez RJ, Keim DR, Sullivan DB, Chenevert TL, Martel W: Magnetic resonance imaging appearance of the muscles in childhood dermatomyositis. J Pediatrics 1990, 117:546–550. DOI: 10.1016/S0022-3476(05)80686-9
20. Adams EM, Chow CK, Premkumar A, Plotz PH: The idiopathic inflammatory myopathies: spectrum of MR imaging findings. Radiographics 1995, 15:563–574. MRI STIR sequences are important and frequently used for the visualization of inflammation in muscle, myofascial tissue, subcutaneous fat, and skin. This paper provides many images to illustrate the morphologic abnormalities in inflammatory diseases.
21. Hernandez RJ, Keim DR, Chenevert TL, Sullivan DB, Aisen AM: Fat-suppressed MR imaging of myositis. Radiology 1992, 182:217–219.
22. Park JH, Olsen NJ, King LE, et al.: MRI and P-31 magnetic resonance spectroscopy detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis. Arthritis Rheum 1995, 38:68–77. Amyopathic dermatomyositis is characterized by a typical erythematous rash along with the absence of muscle weakness and no abnormal laboratory findings. However, these patients often have symptoms of fatigue and lethargy, which can be explained on the basis of metabolic defects detected with the sensitive technology of P-31 MRS. The muscles of the patients with amyopathic DM were normal at rest, but showed inefficient utilization of high energy phosphate compounds (ATP and phosphocreatine) during exercise and substantially decreased oxidative capacity. DOI: 10.1002/art.1780380111
23. Bartlett ML, Ginn L, Beitz L, et al.: Quantitative assessment of myositis in thigh muscles using magnetic resonance imaging. Magn Reson Imaging 1999, 17:183–191. A computerized method for evaluating the severity and extent of muscle inflammation was designed and may prove to be suitable for routine analyses. This partially automated computer program analyzes the MRI STIR images and provides a histogram of signal intensities for distinguishing between normal subjects and mild or moderate/severe disease. The accuracy of the program was verified by comparison with visual analyses of a radiologist; the method was subsequently used for evaluations in a clinical trial. DOI: 10.1016/S0730-725X(98)00092-7
24. Hernandez RJ, Sullivan DB, Chenevert TL, Keim DR: MR imaging in children with dermatomyositis: musculoskeletal findings and correlation with clinical and laboratory findings. AJR Am J Roentgenol 1993, 161:359–366. Statistically significant correlations between MRI abnormalities and muscle strength are documented for juvenile dermatomyositis patients.
25. Kimball AB, Summers RM, Turner M, et al.: Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Arthritis Rheum 2000, 43:1866–1873. MRI STIR sequences were used to quantitatively study inflammation in the subcutaneous fat, skin, and muscles of patients with JDM. Areas of inflammation in the subcutaneous fat were associated with calcinosis in some patients, suggesting that treatment of subcutaneous edema may prevent or reduce the formation of calcifications. STIR MRI muscle scores were statistically correlated with global disease activity scores. DOI: 10.1002/1529-0131(200008)43:8<1866::AID-ANR24>3.0.CO;2-6
26. Rider LG: Assessment of disease activity and its sequelae in children and adults with myositis. Curr Opin Rheumatol 1996, 8:495–506. DOI: 10.1097/00002281-199611000-00002
27. Vencovsky J, Jarosova K, Machacek S, et al.: Cyclosporin A versus methotrexate in the treatment of polymyositis and dermatomyositis. Scand J Rheumatol 2000, 29:95–102. DOI: 10.1080/030097400750001897
28. Ryder N, Park J, Lawton A, et al.: Magnetic resonance imaging and P-31 MR spectroscopy for evaluation of juvenile dermatomyositis. Arthritis Rheum 1994, 37:243.
29. Steinbach LS, Tehranzadeh J, Fleckenstein JL, Vanarthos WJ, Pais MJ: Human immunodeficiency virus infection: musculoskeletal manifestations. Radiology 1993, 186:833–838.
30. Park JH, Niermann KJ, Ryder NM, et al.: Muscle abnormalities in juvenile dermatomyositis patients. Arthritis Rheum 2000, 43:407–413. Metabolic abnormalities in muscles of patients with JDM were demonstrated with P-31 magnetic resonance spectroscopy and compared with biochemical defects in adult patients with DM. DOI: 10.1002/1529-0131(200010)43:10<2359::AID-ANR25>3.0.CO;2-D
31. Park JH, Nelson AE, Olsen NJ: MRI and P-31 MR spectroscopy in juvenile dermatomyositis: statistical correlation with clinical parameters. Arthritis Rheum 1999, 42:158.
32. Gupta RK, Benkovic JL, Rose ZB: Determination of the free magnesium level in human red blood cells by P-31 MRS. J Biol Chem 1978, 253:6172–6176.
33. Niermann KJ, Park JH, Olsen NJ: Abnormalities in levels of total and ATP-bound Mg2+ in muscles of juvenile dermatomyositis patients. Arthritis Rheum 2000, 43:767.
34. Pachman LM: Polymyositis and dermatomyositis in children. In Oxford Textbook of Rheumatology, edn 2. Edited by Maddison PJ, Isenberg D, Woo P, Glass DN. New York: Oxford University Press; 1998:1287–1300.
35. Stonecipher MR, Jorizzo JL, Monu J, Walker F, Sutej PG: Dermatomyositis with normal muscle enzyme concentrations: a single-blind study of the diagnostic value of magnetic resonance imaging and ultrasound. Arch Dermatol 1994, 130:1294–1299. This paper shows the utility of MRI and ultrasound for the accurate diagnosis of amyopathic dermatomyositis. Although ultrasound examinations were simpler and more cost effective, MRI was more sensitive and specific. Confident diagnosis of amyopathic DM is important for therapeutic planning. DOI: 10.1001/archderm.130.10.1294
36. Stonecipher MR, Callen JP, Jorizzo JL: The Red Face: dermatomyositis. Clin Dermatol 1993, 11:261–273. DOI: 10.1016/0738-081X(93)90062-H
37. Euwer RL, Southeimer RD: Amyopathic dermatomyositis. J Am Acad Dermatol 1992, 26:506–508. DOI: 10.1016/S0190-9622(08)80591-9
38. Rider LG, Miller FW: Idiopathic inflammatory muscle disease: clinical aspects. Bailliere’s Clin Rheumatol 2000, 14:37–54. Inflammatory muscle diseases are characterized in this detailed, comprehensive review that should be of great interest to clinicians and investigators. DOI: 10.1053/berh.1999.0076
39. Kari S, Olsen NJ, Park JH: Evaluation of muscle diseases using artificial Neural Network analyses of P-31 MR spectroscopy data. Magn Reson Med 1995, 34:664–672. Artificial neural networks were designed to analyze metabolic P-31 MRS data to accurately classify DM and amyopathic DM patients. The levels of biochemical compounds in muscles (ATP, phosphocreatine, inorganic phosphate, and phosphodiesters) were weighted repeatedly and simultaneously by the computerized network, resulting in a classification of patients on a quantitative percentage basis. The simultaneous weighting of biochemical compounds by the network also affords a quantitative method for longitudinal analysis of immunosuppressive therapy. DOI: 10.1002/mrm.1910340504
40. Park JH, Kari S, King LE, Olsen NJ: Analysis of P-31 MR spectroscopy data using artificial neural networks for longitudinal evaluation of muscle diseases: dermatomyositis. NMR Biomed 1998, 11:245–256. DOI: 10.1002/(SICI)1099-1492(199806/08)11:4/5<245::AID-NBM513>3.0.CO;2-4
41. Fujitake J, Ishikawa Y, Fujii H, et al.: Magnetic resonance imaging of skeletal muscles in polymyositis. Muscle Nerve 1997, 20:1463–1467. DOI: 10.1002/(SICI)1097-4598(199711)20:11<1463::AID-MUS18>3.0.CO;2-2
42. Reimers CD, Schedel H, Fleckenstein JL, et al.: Magnetic resonance imaging of skeletal muscles in idiopathic inflammatory myopathies of adults. J Neurol 1994, 241:306–314. DOI: 10.1007/BF00868438
43. Arahata K, Engel AG: Monoclonal antibody analysis of mononuclear cells in myopathies, I: Quantitation of subsets according to diagnosis and site of accumulation and counts of muscle fibers invaded by T cells. Ann Neurol 1984, 16:193–208. DOI: 10.1002/ana.410160206
44. Hernandez RJ, Keim DR, Chenevert TL, Sullivan DB, Aisen AM: Fat-suppressed MRI of myositis. Radiology 1992, 182:217–219.
45. Reimers CD, Schlotter B, Eicke BM, Witt TN: Calf enlargement in neuromuscular diseases: a quantitative ultrasound study in 350 patients and review of the literature. J Neurol Sci 1996, 143:46–56. DOI: 10.1016/S0022-510X(96)00037-8
46. Newman ED, Kurland RJ: P-31 magnetic resonance spectroscopy in polymyositis and dermatomyositis. Arthritis Rheum 1992, 35:199–202. DOI: 10.1002/art.1780350212
47. Olsen NJ, Vital TL, Schulman M, et al.: Distinct patterns of muscle involvement in dermatomyositis and polymyositis as characterized by magnetic resonance imaging and spectroscopy. Arthritis Rheum 1992, 35:87.
48. Park JH, Olsen NJ, Vital T, Gilpin L, Price RR: MR imaging and P-31 MR spectroscopy for quantitative comparison of inflammatory myopathies: dermatomyositis, polymyositis, and inclusion body myositis. Radiology 1992, 185:322.
49. Sekul EA, Chow C, Dalakas MC: Magnetic resonance imaging of the forearm as a diagnostic aid in patients with sporadic inclusion body myositis. Neurology 1997, 48:863–866. An MRI study of the upper extremities of patients with IBM demonstrated abnormalities in the flexor digitorum profundus of 20 of 21 patients. Fat replacement and occasional inflammation correlated with disease severity, not duration. This finding of selective muscle involvement suggests that MR imaging of the forearm may be useful in early diagnosis of IBM.
50. Sirakumar K, Dalakas MC: The spectrum of familial inclusion body myopathies in 13 families and a description of a quadriceps-sparing phenotype non-Iranian Jews. Neurology 1996, 47:977–984. In hereditary IBM of certain non-Iranian Jews, there was a unique sparing of the quadriceps muscle. This selective sparing is not understood but interesting because in most IBM patients, involvement of the anterior muscles of the thigh is a characteristic of the disease.
51. Lodi R, Taylor DJ, Tabrizi SJ, et al.: Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by 31P-magnetic resonance spectroscopy. Brain 1998, 121:2119–2126. In the muscles of patients with IBM, low levels of phosphocreatine (PCr) along with high levels of inorganic phosphate (Pi) and ADP are consistent with muscle atrophy and weakness. However, the resynthesis and recovery of PCr after exercise were normal, indicating that mitochondrial oxidative phosphorylation was not altered. In contrast, mitochondrial function and PCr resynthesis are defective during exercise and recovery in DM and JDM. DOI: 10.1093/brain/121.11.2119
52. Argov Z, Taivassalo T, Destefano N, et al.: Intracellular phosphates in inclusion body myositis: a 31P magnetic resonance spectroscopy study. Muscle Nerve 1998, 21:1523–1525. DOI: 10.1002/(SICI)1097-4598(199811)21:11<1523::AID-MUS22>3.0.CO;2-#
53. Fleckenstein JL, Crues JV, Reimers CD: Muscle Imaging in Health and Disease. New York: Springer-Verlag; 1996.
54. Vahlensieck M, Genant HK, Reiser M: MRI of the musculoskeletal system. New York: Theime Medical Publishers; 1999.
55. Haddad MG, West RL, Treadwell EL, Fraser DD: Diagnosis of inflammatory myopathy by percutaneous needle biopsy with demonstration of the focal nature of myositis. Am J Clin Pathol 1994, 101:661–664.